Fredric N. Eshelman - Sep 23, 2022 Form 4 Insider Report for Aravive, Inc. (ARAV)

Role: Executive Chairman, Director, 10%+ Owner
Signature: /s/ ESHELMAN VENTURES, LLC, By: /s/ Fredric N. Eshelman, Name: Fredric N. Eshelman, Title: Managing Member
Stock symbol: ARAV
Transactions as of: Sep 23, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/26/2022, 04:07 PM
Previous filing: Apr 4, 2022
Next filing: Oct 26, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARAV	Stock Option (Right to Buy)	Award	$0	+97.1K		$0.00	97.1K	Sep 23, 2022	Common Stock	97.1K	$0.92	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options vest pro rata on a monthly basis commencing on October 23, 2022 for the next 12 months with full vesting, if not fully vested at such time, on the date of Aravive, Inc.'s next annual meeting of stockholders.

Remarks:

Dr. Fredric Eshelman is the Executive Chairman of the Board of Directors of Aravive, Inc. and is the founder and principal of Eshelman Ventures, LLC.